Dermatology

Strategic Research Insights (SRI) has extensive expertise in dermatology, conducting comprehensive research projects both in the US and globally across a broad range of dermatological conditions. SRI’s portfolio includes psoriasis, psoriatic arthritis, hidradenitis suppurativa (HS), atopic dermatitis, melanoma, acne, rosacea, and chronic idiopathic urticaria (CIU). SRI supports clients throughout the product lifecycle with pre-launch demand estimations, qualitative and quantitative visual aid testing, and launch tracking, as well as pre-launch promotion mix optimization.

We have conducted dermatological disease studies across 30 countries, including the US, Canada, core and extended European Union markets, Japan, and Latin America. Research modalities include physician and patient trackers, awareness, trial and usage (ATU) studies, payer research, message recall assessments, launch readiness preparation, conjoint analysis, strategic positioning, patient and caregiver research, message development, direct-to-consumer (DTC) tracking, forecasting, and hybrid segmentations involving qualitative and quantitative research, as well as Big Data Analytics.

SRI’s dermatology team brings a deep understanding of both clinical and commercial challenges, helping clients formulate evidence-based insights to optimize brand strategies, stakeholder engagement, and market penetration. The firm’s work supports nuanced messaging and segmentation designed to meet the unique needs of dermatology patients and healthcare providers, leveraging scalable global research and robust analytic frameworks. Our expertise includes biologic treatments and broader immunology, delivering strategic guidance on launches, market access, and lifelong brand management in competitive dermatology markets.